Pfizer and partner BioNTech to seek emergency-use authorization for COVID-19 vaccine Friday By: MarketWatch November 20, 2020 at 07:45 AM EST Pfizer/BioNTech said they intend to submit applications to other regulatory agencies worldwide in coming days. Read More >> Related Stocks: Astrazeneca Plc ADR Biontech Se ADR Curevac N.V. Gsk Plc ADR Johnson & Johnson Moderna Inc Novavax Inc Pfizer Sanofi-Aventis S.A. ADR
